English | Español
Press release submission | May 1, 2019

LEANMD, INC.: Looks to End the Obesity Epidemic One Person at a Time
Press release submission | Apr 25, 2019

PROVENTION BIO, INC.: Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease
Press release submission | Apr 23, 2019

ELI LILLY AND COMPANY: Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Press release submission | Apr 19, 2019

TELA BIO, INC.: Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery
Press release submission | Apr 15, 2019

MESOTHELIOMA COMPENSATION CENTER: Now Offers to Make Certain That a Nuclear Power Worker with Mesothelioma or Asbestos Exposure Lung Cancer Gets Accelerated Compensation with The Help of Attorney Erik Karst and His Colleagues at Karst von Oiste
Press release submission | Apr 11, 2019

BD: Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
Press release submission | Apr 10, 2019

TREMOTYX BIOMEDICAL LAB: Debuts Plant Stem Cell-Based Eczema Treatment in the U.S.
Press release submission | Apr 4, 2019

VARIAN MEDICAL SYSTEM: Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’